Today I have the opportunity to speak with Dr. George Tetz. His name may sound familiar to many of you as I have interviewed him in the past with regards to his work connecting bacteriophages with Parkinson’s disease.
Today, we explore his latest research related to coronavirus (COVID-19). Yes, it’s technical, but his discovery of homologous prion sequences in the virus, and, in its human receptor site is mind-blowing.
Let me tell you a bit more about Dr. Tetz.
George Tetz, MD, PhD is CEO of the Human Microbiology Institute in New York City. His research focuses on the study of bacteriophages: viruses that infect bacteria. Tetz studies how bacteriophages can contribute to microbiome dysbiosis in a range of human chronic inflammatory conditions. He also examines how bacteriophages can act as novel mammalian pathogens by interacting directly with human cells and the host immune response. His recent findings show an early role for bacteriophage activity in conditions such as Parkinson’s disease, Type 1 Diabetes, and “leaky-gut” syndrome.
